No abstract available
MeSH terms
-
Adamantane / analogs & derivatives
-
Adamantane / therapeutic use
-
Benzhydryl Compounds / therapeutic use
-
Blood Glucose / drug effects
-
Canagliflozin / therapeutic use
-
Clinical Trials as Topic
-
Diabetes Mellitus, Type 1 / blood
-
Diabetes Mellitus, Type 1 / drug therapy*
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Dipeptides / therapeutic use
-
Drug Therapy, Combination
-
Glucosides / therapeutic use
-
Glycated Hemoglobin / drug effects
-
Glycosides / therapeutic use
-
Humans
-
Hypoglycemia / chemically induced
-
Hypoglycemic Agents / therapeutic use*
-
Insulin / therapeutic use
-
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
-
Treatment Outcome
Substances
-
Benzhydryl Compounds
-
Blood Glucose
-
Dipeptides
-
Glucosides
-
Glycated Hemoglobin A
-
Glycosides
-
Hypoglycemic Agents
-
Insulin
-
Sodium-Glucose Transporter 2 Inhibitors
-
hemoglobin A1c protein, human
-
Canagliflozin
-
dapagliflozin
-
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
-
saxagliptin
-
Adamantane